Results 161 to 170 of about 457,451 (216)

RADT-41. THE ROLE OF RADIOTHERAPY IN RESECTED NON-SMALL CELL LUNG CANCER BRAIN METASTASES TREATED WITH CNS-ACTIVE TYROSINE KINASE INHIBITORS [PDF]

Abrar Choudhury, Florence Keane, Lin Zhu, Sarah Waliany, Ariel Marciscano, Justin Gainor, Zofia Piotrowska, Jessica Lin, Kevin Oh, Daniel Cahill, Priscilla Brastianos, Rifaquat Rahman, Shyam Tanguturi, Nayan Lamba, Daphne Haas-Kogan, Henning Willers, Helen Shih, Ayal Aizer, Melin Khandekar   +18 more
openalex   +1 more source

Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia. [PDF]

Cancer
Bao M, Zhang XS, Li ZR, Yu L, Gale RP, Zhao SS, Ye F, Yan CC, Huang XJ, Jiang Q.   +9 more
europepmc   +1 more source

Impact of aryloxy-linked quinazolines: A novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors

, 2011
Antonio Garofalo, Laurence Goossens, Perrine Six, Amélie Lemoine, Séverine Ravez, Amaury Farce, Patrick Depreux   +6 more
openalex   +1 more source

Exploring research frontiers and emerging trends of tyrosine kinase inhibitors in the treatment of colorectal cancer. [PDF]

BMC Cancer
Li X, Chen Z, Yin J, Shen X, Li H.
europepmc   +1 more source

Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases

, 2010
Brian E. Fink, Derek Norris, Harold Mastalerz, Ping Chen, Bindu Goyal, Yufen Zhao, Soong‐Hoon Kim, Gregory D. Vite, Francis Y. Lee, Hongjian Zhang, Simone Oppenheimer, John S. Tokarski, Tai W. Wong, Ashvinikumar V. Gavai   +13 more
openalex   +1 more source

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia. [PDF]

EJHaem
Fernando F, Wasko C, Johns B, Claudiani S, Khan A, Innes AJ, Milojkovic D, Apperley JF.   +7 more
europepmc   +1 more source

Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma

, 2015
Jing Zhang, Ying Tian, Cong Xue, Zhihuang Hu, Li Zhang, Yuanyuan Zhao   +5 more
openalex   +2 more sources

Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar. [PDF]

Discov Oncol
Ghasoub R, Hamad A, El Akiki S, Fareed S, Ellahie A, Ismael O, Yassin MA.   +6 more
europepmc   +1 more source

Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon <i>EGFR</i> Mutations-An In Vitro Study. [PDF]

Cells
Oiki H, Suda K, Hamada A, Fujino T, Obata K, Kobayashi Y, Sakai K, Fukuda S, Ohara S, Ito M, Soh J, Nishio K, Mitsudomi T, Tsutani Y.   +13 more
europepmc   +1 more source

Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms‐Like Tyrosine Kinase‐1/Placental Growth Factor Ratio [PDF]

C. H. Quaak, Ans C.M. Kluivers, Sara J. Baart, H. T. Smeele, Rugina I. Neuman, Langeza Saleh, W Visser, A.H. Jan Danser, Radboud J. E. M. Dolhain   +8 more
openalex   +1 more source